Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

POLYPID LTD.

(PYPD)
  Bericht
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über POLYPID LTD.
18.11.PolyPid Hits Patient Enrollment Milestone in Late-Stage Trial of Anti-Bacterial Product
18.11.POLYPID : Announces 500th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX100..
18.11.PolyPid Announces 500th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX&#..
18.11.Polypid Announces 500Th Patient Enrolled in Shield I Phase 3 Clinical Trial of D-Plex10..
16.11.PolyPid Appoints New Oncology Advisory Board Member
16.11.PolyPid Appoints Frederick Lang to New Oncology Advisory Board Member
10.11.PolyPid Ltd. Reports Third Quarter 2021 Financial Results and Provides Corporate Update
10.11.PolyPid Ltd. Reports Third Quarter 2021 Financial Results and Provides Corporate Update..
10.11.PolyPid Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended Septe..
01.11.PolyPid to Report Third Quarter 2021 Financial Results and Operational Highlights on No..
20.09.POLYPID : to Present at Upcoming Cantor Fitzgerald Global Healthcare Conference
20.09.POLYPID LTD.(NASDAQGM : PYPD) added to S&P Global BMI Index
13.09.POLYPID : Says Pre-Clinical OncoPLEX Data Shows Tumor Growth Inhibition
13.09.POLYPID : Announces Positive Preclinical Data of its Intra-tumoral OncoPLEX in Brain Cance..
13.09.POLYPID : Announces Positive Preclinical Data of its Intra-tumoral OncoPLEX in Brain Cance..
13.09.PolyPid Announces Positive Preclinical Data of its Intra-tumoral OncoPLEX in Brain Canc..
17.08.POLYPID : to Present at First World Association Against Infection in Orthopaedics and Trau..
11.08.POLYPID : Reports Second Quarter 2021 Financial Results and Provides Corporate Update (For..
11.08.PolyPid Ltd. Reports Second Quarter 2021 Financial Results and Provides Corporate Updat..
11.08.POLYPID : Reports Second Quarter 2021 Financial Results and Provides Corporate Update
11.08.PolyPid Ltd. Announces Earnings Results for the Second Quarter and Six Months Ended Jun..
09.08.POLYPID : to Present at the Investor Summit Virtual Conference on August 18, 2021
28.07.POLYPID : to Report Second Quarter 2021 Financial Results and Operational Highlights on Au..
12.07.POLYPID : Strengthens Executive Team, Appointing Dr. Anthony Senagore as Senior Medical Di..
12.07.PolyPid Ltd. Appoints Anthony Senagore as Senior Medical Director
02.07.POLYPID : Sales Agreement (Form 6-K)
23.06.PolyPid Presents today at The Raymond James Human Health Innovation Conference
02.06.PolyPid to Present at Upcoming Healthcare Investor Conferences
19.05.POLYPID : Announces Positive FDA Type B Meeting Feedback for D-PLEX₁₀₀ D..
19.05.POLYPID : Phase 3 Study for Infection Treatment Gets Positive FDA Response
19.05.POLYPID : FDA Agreed that a Single Pivotal Phase 3 Study is Sufficient for Potential Appro..
19.05.PolyPid Ltd. Announces Positive FDA Type B Meeting Feedback for D-Plex Development Prog..
14.05.POLYPID : Reports First Quarter 2021 Financial Results and Provides Corporate Update (Form..
12.05.Polypid Ltd. Announces Consolidated Unaudited Earnings Results for the First Quarter En..
12.05.POLYPID : Reports First Quarter 2021 Financial Results and Provides Corporate Update
04.05.PolyPid Ltd. Announces Resignation of Stanley Stern as Director
29.04.POLYPID : to Report First Quarter 2021 Financial Results and Operational Highlights on May..
23.02.POLYPID : to Participate in Upcoming Investor Conferences
16.02.PolyPid Announces 100th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX&#..
16.02.Polypid Ltd. Announces 100Th Patient Enrolled in Shield I Phase 3 Clinical Trial of D-P..
10.02.POLYPID : Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financia..
10.02.PolyPid Ltd. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and..
27.01.POLYPID : to Report Fourth Quarter and Full Year 2020 Financial Results and Operational Hi..
202013,296,451 Ordinary Shares of PolyPid Ltd. are subject to a Lock-Up Agreement Ending on..
2020Certain Stock Options of PolyPid Ltd. are subject to a Lock-Up Agreement Ending on 23-D..
2020Certain Warrants of PolyPid Ltd. are subject to a Lock-Up Agreement Ending on 23-DEC-20..
2020POLYPID : Reports Positive Preclinical Data From Cancer Therapy Program; Shares Jump
2020POLYPID : Announces Positive Preclinical Data from OncoPLEX Intra-Tumoral Cancer Therapy P..
2020PolyPid Announces Positive Preclinical Data from OncoPLEX Intra-Tumoral Cancer Therapy ..
2020POLYPID : Starts Second Late-Stage Trial of Drug Candidate Used to Prevent Post-Stomach Su..
2020POLYPID INITIATES SHIELD II : Second Phase 3 Clinical Trial of D-PLEX₁₀₀..
2020POLYPID INITIATES SHIELD II : Second Phase 3 Clinical Trial of D-PLEX100 for the Preventio..
2020POLYPID : to Host Key Opinion Leader Call Discussing D-PLEX₁₀₀ and the P..
2020SECTOR UPDATE : Health Care Stocks Largely Sit Out Tuesday Market Gains
2020SECTOR UPDATE : Health Care
2020SECTOR UPDATE : Health Care Stocks Mixed During Tuesday's Early Trading
2020POLYPID : Secures FDA Breakthrough Therapy Designation for D-Plex100 Product Candidate; Sh..
2020POLYPID : Granted Breakthrough Therapy Designation from FDA for D-PLEX₁₀₀..
2020PolyPid Granted Breakthrough Therapy Designation from FDA for D-PLEX₁₀̀..
2020PolyPid Ltd. Granted Breakthrough Therapy Designation from FDA for D-PLEX100 for the Pr..
2020POLYPID : Narrows Q3 Loss
2020POLYPID : Provides Corporate Update and Reports Third Quarter 2020 Financial Results
2020PolyPid Ltd. Announces Unaudited Financial Results for the Three and Nine Months Ended ..
2020PolyPid Ltd. Provides Corporate Update and Reports Third Quarter 2020 Financial Results
2020POLYPID : to Participate in Three Upcoming Investor Conferences
2020PolyPid to Participate in Three Upcoming Investor Conferences
2020POLYPID : to Report Third Quarter 2020 Financial Results and Operational Highlights on Nov..
2020PolyPid to Report Third Quarter 2020 Financial Results and Operational Highlights on No..
2020PolyPid Ltd. Provides Corporate Update and Reports Second Quarter 2020 Financial Result..
2020PolyPid Ltd. Reports Unaudited Consolidated Earnings Results for the Second Quarter and..
2020PolyPid to Report Second Quarter 2020 Financial Results and Operational Highlights on A..
2020PolyPid Granted Fast Track Designation from FDA for D-PLEX₁₀₀ for Pre..
2020FDA Grants Fast Track Designation to PolyPid Ltd. for D-PLEX100 for Prevention of Surgi..
2020PolyPid to Present Phase 2 Results of D-PLEX₁₀₀ for the Prevention of..
2020PolyPid Ltd. Initiates First Phase 3 Clinical Trial of D-PLEX100 for the Prevention of ..
1  2Weiter
Anstehende Branchentermine